VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_21-vv-02109
Package ID: USCOURTS-cofc-1_21-vv-02109
Petitioner: Jerome Jao
Filed: 2021-04-15
Decided: 2025-05-20
Vaccine: influenza
Vaccination date: 2018-10-30
Condition: chronic inflammatory demyelinating polyneuropathy (CIDP)
Outcome: compensated
Award amount USD: 125000

AI-assisted case summary:
Jerome Jao filed a petition on October 29, 2021, alleging that he developed chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of an influenza vaccine received on October 30, 2018. He further alleged that he experienced residual effects of this injury for more than six months. The respondent denied that the flu vaccine caused Mr. Jao's CIDP or any other injury. Despite maintaining their positions, both parties agreed to settle the case. They filed a stipulation on April 15, 2025, agreeing that the issues could be resolved and that Mr. Jao should be awarded compensation. Chief Special Master Brian H. Corcoran reviewed the file and adopted the stipulation as the decision. The stipulation awarded Mr. Jao a lump sum of $125,000.00 as compensation for all damages available under the Act. The court directed that judgment be entered accordingly. Petitioner was represented by Leah V. Durant of the Law Offices of Leah V. Durant, PLLC, and respondent was represented by James V. Lopez of the U.S. Department of Justice. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses.

Theory of causation field:
Petitioner Jerome Jao alleged that an influenza vaccine administered on October 30, 2018, caused him to develop chronic inflammatory demyelinating polyneuropathy (CIDP) with residual effects lasting more than six months. The respondent denied causation. The parties reached a stipulation on April 15, 2025, agreeing to settle the case with a compensation award. Chief Special Master Brian H. Corcoran adopted the stipulation, awarding Petitioner $125,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_21-vv-02109-0
Date issued/filed: 2025-05-20
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 04/15/2025) regarding 34 DECISION Stipulation/Proffer. Signed by Chief Special Master Brian H. Corcoran. (mva) Service on parties made.
--------------------------------------------------------------------------------
Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 21-2109V
* * * * * * * * * * * * * * * * * * * * * * * * *
*
JEROME JAO, * Chief Special Master Corcoran
*
Petitioner, * Filed: April 15, 2025
*
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * *
Leah V. Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for Petitioner.
James V. Lopez, U.S. Dep’t of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On October 29, 2021, Jerome Jao filed a petition seeking compensation under the National
Vaccine Injury Compensation Program (the “Vaccine Program”). 2 Petitioner alleges that he
developed chronic inflammatory demyelinating polyneuropathy (“CIDP”) as a result of an
influenza (“flu”) vaccine her received on October 30, 2018. Moreover, Petitioner alleges that he
experienced residual effects of this injury for more than six months.
Respondent denies that the flu vaccine caused Petitioner to suffer from CIDP, or any other
injury, or his current condition. Nonetheless both parties, while maintaining their above-stated
positions, agreed in a stipulation (filed on April 15, 2025) that the issues before them could be
settled, and that a decision should be entered awarding Petitioner compensation.
1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public
in its present form. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,
100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”).
Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix).

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 2 of 7
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
(as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the
terms set forth therein.
The stipulation awards:
• A lump sum of $125,000.00 to be paid through an ACH deposit to Petitioner’s
counsel’s IOLTA account for prompt disbursement to Petitioner.
Stipulation ¶ 8. This amount represents compensation for all damages that would be available
under Section 15(a) of the Act.
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
/s/ Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately)
a notice renouncing their right to seek review.

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 3 of 7

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 4 of 7

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 5 of 7

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 6 of 7

Case 1:21-vv-02109-UNJ Document 38 Filed 05/20/25 Page 7 of 7